Cargando…
Anaphylactoid hypersensitivity reaction from intra-arterial cetuximab: Clinical considerations and management
Intra-arterial infusion of drugs shows promising results in terms of safety and efficacy. Intra-arterial cetuximab, a monoclonal antibody treatment, is currently being tested for its use in head and neck cancers. We present the case of a 45-year-old Asian male who developed an anaphylactoid hypersen...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
SAGE Publications
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6350015/ https://www.ncbi.nlm.nih.gov/pubmed/30728973 http://dx.doi.org/10.1177/2050313X18823447 |